GlassScriptPhysician profile
David M Nudell
NPI 1912070889
$10,426.30
in general payments reported to CMS, 2019-2025
49 companies · $2,381 in 2025
The $2,381 reported for 2025 was more than what 96% of Pediatric Urology providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,644 · 2020: $801 · 2021: $928 · 2022: $1,656 · 2023: $1,749 · 2024: $1,267 · 2025: $2,381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,198 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,197.86 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $2,171.62 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $1,674.50 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $813.73 | 2019-2025 | Erleada, Balversa, Akeega |
| Dendreon Pharmaceuticals LLC | $561.37 | 2019-2024 | Provenge |
| Abbvie INC. | $487.48 | 2019-2025 | |
| Amgen INC. | $384.97 | 2019-2023 | Xgeva |
| Antares Pharma, INC. | $349.85 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Urovant Sciences INC | $325.96 | 2021-2022 | |
| Pfizer INC. | $291.09 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $261.00 | 2019-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $253.17 | 2019-2025 | |
| Coloplast Corp | $234.32 | 2019-2025 | Speedicath |
| Zyla Life Sciences, INC. | $225.23 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $224.62 | 2020-2025 | Lynparza |
| Accord Healthcare, INC. | $196.29 | 2022-2025 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Nudell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.